Cargando…

Pharmacokinetics and Safety of a Novel Oral Liquid Formulation of 13-cis Retinoic Acid in Children with Neuroblastoma: A Randomized Crossover Clinical Trial

SIMPLE SUMMARY: The availability of a child-friendly drug formulation can be an important determinant of therapeutic success. 13-cis-retinoic acid (13-CRA) is a key component of high-risk neuroblastoma treatment protocols, and yet there is no such formulation available in any country worldwide. Typi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Veal, Gareth J., Tweddle, Deborah A., Visser, Johannes, Errington, Julie, Buck, Helen, Marange, Josephine, Moss, Jon, Joseph, Shiju, Mulla, Hussain
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8070696/ https://www.ncbi.nlm.nih.gov/pubmed/33919763 http://dx.doi.org/10.3390/cancers13081868

Ejemplares similares

Pharmacokinetics and metabolism of 13-cis-retinoic acid (isotretinoin) in children with high-risk neuroblastoma – a study of the United Kingdom Children's Cancer Study Group
por: Veal, G J, et al.
Publicado: (2007)

Increasing the intracellular availability of all-trans retinoic acid in neuroblastoma cells
por: Armstrong, J L, et al.
Publicado: (2005)

Pharmacokinetics and effects on plasma retinol concentrations of 13-cis-retinoic acid in melanoma patients.
por: Formelli, F., et al.
Publicado: (1997)

A randomized trial of 13-Cis retinoic acid in children with advanced neuroblastoma after high-dose therapy
por: Kohler, J A, et al.
Publicado: (2000)

Bioavailability and dose-dependent anti-tumour effects of 9-cis retinoic acid on human neuroblastoma xenografts in rat
por: Ponthan, F, et al.
Publicado: (2001)

Pharmacokinetics and Pharmacogenetics of Cyclophosphamide in a Neonate and Infant Childhood Cancer Patient Population
por: Barnett, Shelby, et al.
Publicado: (2021)

Comparison of the Effects of 13-cis Retinoic Acid and Melatonin on the Viabilities of SH-SY5Y Neuroblastoma Cell Line
por: Tosun, Murat, et al.
Publicado: (2015)

Molecular targeting of retinoic acid metabolism in neuroblastoma: the role of the CYP26 inhibitor R116010 in vitro and in vivo
por: Armstrong, J L, et al.
Publicado: (2007)

Carboplatin therapeutic monitoring in preterm and full-term neonates
por: Veal, Gareth J., et al.
Publicado: (2015)

Characterisation of the Clinical Pharmacokinetics of Actinomycin D and the Influence of ABCB1 Pharmacogenetic Variation on Actinomycin D Disposition in Children with Cancer
por: Hill, Christopher R., et al.
Publicado: (2014)

Cyclophosphamide pharmacokinetics and pharmacogenetics in children with B-cell non-Hodgkin's lymphoma
por: Veal, Gareth J., et al.
Publicado: (2016)

9-cis retinoic acid induces neurorepair in stroke brain
por: Yu, Seong-Jin, et al.
Publicado: (2017)

Preclinical evaluation of the first intravenous small molecule MDM2 antagonist alone and in combination with temozolomide in neuroblastoma
por: Chen, Lindi, et al.
Publicado: (2019)

Generation of evidence-based carboplatin dosing guidelines for neonates and infants
por: Barnett, Shelby, et al.
Publicado: (2023)

Usefulness of (18)F-Fluorodeoxyglucose Positron Emission Tomography for Follow-Up of 13-cis-Retinoic Acid Treatment for Residual Neuroblastoma After Myeloablative Chemotherapy
por: Sato, Yuya, et al.
Publicado: (2015)

Retinoic acid induces differentiation in neuroblastoma via ROR1 by modulating retinoic acid response elements
por: Illendula, Abhinav, et al.
Publicado: (2020)

Targeting Neuroblastoma Stem Cells with Retinoic Acid and Proteasome Inhibitor
por: Hämmerle, Barbara, et al.
Publicado: (2013)

Changes in Gene Expression Profiling of Apoptotic Genes in Neuroblastoma Cell Lines upon Retinoic Acid Treatment
por: Celay, Jon, et al.
Publicado: (2013)

Retinoic acid-induced CHD5 upregulation and neuronal differentiation of neuroblastoma
por: Higashi, Mayumi, et al.
Publicado: (2015)

Retinoic acid rewires the adrenergic core regulatory circuitry of childhood neuroblastoma
por: Zimmerman, Mark W., et al.
Publicado: (2021)

Pharmacokinetics of a Single Dose of Turmeric Curcuminoids Depends on Formulation: Results of a Human Crossover Study
por: Fança-Berthon, Pascale, et al.
Publicado: (2021)

Metabolomics research on potential role for 9‐cis‐retinoic acid in breast cancer progression
por: Wu, Jing, et al.
Publicado: (2018)

The influence of duloxetine on detrusor overactivity in rats with depression induced by 13-cis-retinoic acid
por: Wróbel, Andrzej, et al.
Publicado: (2017)

Dual effects of 9-cis retinoic acid on ACTH-dependent hyperplastic adrenal tissues
por: Pecori Giraldi, Francesca, et al.
Publicado: (2021)

Targeting the DNA Damage Response for the Treatment of High Risk Neuroblastoma
por: Southgate, Harriet E. D., et al.
Publicado: (2020)

Alterations in neuroblastoma ganglioside synthesis by induction of GD1b synthase by retinoic acid
por: Hettmer, S, et al.
Publicado: (2004)

Nuclear GRP75 Binds Retinoic Acid Receptors to Promote Neuronal Differentiation of Neuroblastoma
por: Shih, Yu-Yin, et al.
Publicado: (2011)

Effect of retinoic acid and delta-like 1 homologue (DLK1) on differentiation in neuroblastoma
por: Kim, Yuri
Publicado: (2010)

Redox balance influences differentiation status of neuroblastoma in the presence of all-trans retinoic acid
por: Silvis, Anne M., et al.
Publicado: (2015)

Differentiating Neuroblastoma: A Systematic Review of the Retinoic Acid, Its Derivatives, and Synergistic Interactions
por: Bayeva, Nadiya, et al.
Publicado: (2021)

Vincristine dosing, drug exposure and therapeutic drug monitoring in neonate and infant cancer patients
por: Barnett, Shelby, et al.
Publicado: (2022)

13-Cis Retinoic Acid Activates Regenerative Behavior of Primary Human Lymphatic Endothelial Cells
por: Hsu, Jerry, et al.
Publicado: (2021)

13-cis-retinoic acid inhibits the self-renewal, migration, invasion and adhesion of cholangiocarcinoma cells
por: Butsri, Siriwoot, et al.
Publicado: (2023)

Energy status regulates levels of the RAR/RXR ligand 9-cis-retinoic acid in mammalian tissues: Glucose reduces its synthesis in β-cells
por: Yoo, Hong Sik, et al.
Publicado: (2023)

Pharmacokinetics of All‐trans Retinoic Acid in Pediatric Patients with Leukemia
por: Takitani, Kimitaka, et al.
Publicado: (1995)

MYCN sensitizes neuroblastoma to the MDM2-p53 antagonists Nutlin-3 and MI-63
por: Gamble, Laura D., et al.
Publicado: (2011)

Randomized Controlled Crossover Trials of the Pharmacokinetics of PRC-063, a Novel Multilayer Extended-Release Formulation of Methylphenidate, in Healthy Adults
por: Katzman, Martin A., et al.
Publicado: (2020)

An open-label, crossover study to compare different formulations and evaluate effect of food on pharmacokinetics of pimitespib in patients with advanced solid tumors
por: Komatsu, Yoshito, et al.
Publicado: (2022)

A systematic review of re-induction chemotherapy for children with relapsed high-risk neuroblastoma
por: Herd, Fiona, et al.
Publicado: (2019)

Post-surgical treatment of thyroid carcinoma in dogs with retinoic acid 9 cis improves patient outcome
por: Castillo, V., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_6p8ti8rilm7hbtj8ti0nav8j09